Menu

Important Document

Important Document

Sr. No. Title Details
251 31th Steering Committee Meeting of NIPERs
252 Major achievements during March 2018 -IC Section
253 Corrigundum-Hiring of One Principal Legal Consultant in NPPA on contract basis
254 Invoking Para 3 of DPCO, 2013 under acute shortage of formulation Viraferonpeg 100 mcg Injection
255 Hiring of One Principal Legal Consultant in NPPA on contract basis
256 Hiring of seven (07) Senior/Principal Associates in NPPA on contract basis
257 Recruitment of Chief Executive Officer (CEO) in BPPI
258 List of 3rd India Pharma/Medical Device Awards
259 Statement of Accounts of NIPER Hyderabad 2014-15
    260 Statement of Accounts of NIPER S.A.S. Nagar 2015-16
      261 Statement of Accounts of NIPER S.A.S. Nagar 2014-15
        262 Disposal of unserviceable/condemned staff car DL-2CQ 0769.
        263 Major achievements during October 2017 - IC Section
        264 Last date for receipt of nomination of 3rd India Pharma/Medical Device Awards was 31.10.2017. It has been further extended upto 30.11.2017.
        265 3rd India Pharma / Medical Device Awards
        266 Hiring of Consultant(Hindi) in NPPA on contract basis.
          267 Hiring of Principal Legal Consultant in NPPA on contract basis
          268 Request for Proposal for Publicity Activities for the Schemes of Department of Pharmaceuticals -Regarding
          269 Nomination of 3rd India Pharma Awards and Medical Device Awards has been extended upto 31.10.2017.
          270 Request for Proposal for Publicity Activities for the Schemes of Department of Pharmaceuticals
          271 Ensuring compliance of the price capping of the Coronary Stents along with maintaining its uninterrupted supply -regarding
          272 Ensuring compliance of the price capping of the Primary Knee and Revision Knee along with maintaining its uninterrupted supply -regarding
          273 Hiring of Senior Consultants and Consultant in NPPA on contract basis
          274 Message of Honorable Secretary Department of Pharmaceuticals on Hindi Day
          275 Report of Department of Pharmaceuticals on Swachhata Pakhwada During 16-31st August 2017
          276 Major achievements during August 2017 IC Section
          277 Message from Honorable Minister (C&F) on Swachhta Pakhwada
          278 Message from Honorable MOS (C&F) on Swachhta Pakhwada
          279 FAQs on GST on drugs and Pharmaceuticals
          280 3rd India Pharma Awards and Medical Device Awards
          281 Minutes of 28th Steering Committee Meeting
          282 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
          283 Appointment of Part - time CVO in Department of Pharmaceuticals
          284 Constitution of GST Facilitation Cell
          285 Application for the post of Director, Niper, Hyderabad
          286 Application form of Technical and Legal Consultant on contract basis
          287 Hiring of Technical consultant and Legal consultant on contract- reg.
          288 Hiring of Technical consultant and Legal consultant on contract- reg.
          289 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.
          290 Minutes of the Meeting held on 09.05.2017 in the Department of Pharmaceuticals regarding preparation of Calendar of Events for organizing Conferences/Seminars/Workshops under Pharmaceutical Promotion and Development Scheme- PPDS
          291 Meeting regarding Grant-in-aid under Pharmaceuticals Promotion & Development Scheme (PPDS)
          292 Composition of NPPA Authority- Regarding
          293 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
          294 Fixation of ceiling price of a scheduled formulation under Para 4 of Drugs (Prices Control) Order, 2013 (DPCO, 2013) - regarding.
          295 Submission of the detailed agreement/contract between the manufacturer and marketer to NPPA. - regarding
          296 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.
          297 Revision of ceiling price due to revision of WPI.
          298 Revision of ceiling price by National Pharmaceutical Pricing Authority (NPPA)
          299 corrigendum-Hiring of consultants on contract basis
          300 Hiring of Technical consultant and Legal consultant on contract

          Pages